MYPT1 reduction is a pathogenic factor of erectile dysfunction
Authors:
Open Access
- 25 July 2022
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 5 (1) , 1-13
Abstract
Erectile dysfunction (ED) is closely associated with smooth muscle dysfunction, but its underlying mechanisms remains incompletely understood. We here reported that the reduced expression of myosin phosphatase target subunit 1 (MYPT1), the main regulatory unit of myosin light chain phosphatase, was critical for the development of vasculogenic ED. Male MYPT1 knockout mice had reduced fertility and the penises displayed impaired erections as evidenced by reduced intracavernous pressure (ICP). The penile smooth muscles of the knockout mice displayed enhanced response to G-Protein Couple Receptor agonism and depolarization contractility and resistant relaxation. We further identified a natural compound lotusine that increased the MYPT1 expression by inhibiting SIAH1/2 E3 ligases-mediated protein degradation. This compound sufficiently restored the ICP and improved histological characters of the penile artery of Mypt1 haploinsufficiency mice. In diabetic ED mice (db/db), the decreased expression of MYPT1 was measured, and ICP was improved by lotusine treatment. We conclude that the reduction of MYPT1 is the major pathogenic factor of vasculogenic ED. The restoration of MYPT1 by lotusine improved the function of injured penile smooth muscles, and could be a novel strategy for ED therapy.Keywords
All Related Versions
This publication has 58 references indexed in Scilit:
- Increased degradation of MYPT1 contributes to the development of tolerance to nitric oxide in porcine pulmonary arteryAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Regulation of MYPT1 stability by the E3 ubiquitin ligase SIAH2Experimental Cell Research, 2010
- Myosin Light Chain Kinase Is Central to Smooth Muscle Contraction and Required for Gastrointestinal Motility in MiceGastroenterology, 2008
- Gene Therapy for Erectile Dysfunction: Fact or Fiction?European Urology, 2006
- Elevated RhoA/Rho‐kinase activity in the aged rat penis: mechanism for age‐associated erectile dysfunctionThe FASEB Journal, 2006
- Efficacy of Sildenafil Citrate in Treatment of Erectile Dysfunction: Effect of Type 2 DiabetesEuropean Urology, 2004
- Erectile Physiological and Pathophysiological Pathways Involved in Erectile DysfunctionJournal of Urology, 2003
- Penile Arteries and ErectionJournal of Vascular Research, 2002
- Contractile properties and proteins of smooth muscles of a calponin knockout mouseThe Journal of Physiology, 2000
- Erectile DysfunctionNew England Journal of Medicine, 2000